Company Filing History:
Years Active: 2018-2023
Title: Innovations in Cancer Research by Uri Tabori
Introduction
Uri Tabori is a notable inventor based in Toronto, Canada, recognized for his significant contributions to cancer research. He holds a total of 3 patents that focus on innovative methods for diagnosing and treating cancer. His work aims to improve patient outcomes through advanced profiling techniques.
Latest Patents
One of Uri Tabori's latest patents is titled "Profiling and treatment of hypermutant cancer." This patent describes a method for profiling tumors by determining the relative proportion of 96 mutation types. The method assigns tumors to specific clusters based on these mutations, allowing for a better understanding of tumor characteristics. Another significant patent is the "Method of diagnosing cancer," which outlines a process for diagnosing cancer in mammals by analyzing DNA methylation in a specific target region of the hTERT promoter. This method compares the methylation signature of a sample to a control, facilitating accurate cancer diagnosis.
Career Highlights
Uri Tabori is affiliated with The Hospital for Sick Children, where he applies his expertise in cancer research. His innovative approaches have the potential to transform cancer diagnostics and treatment, making a lasting impact in the medical field.
Collaborations
Uri collaborates with esteemed colleagues such as Pedro Castelo-Branco and Adam Shlien, contributing to a dynamic research environment focused on advancing cancer therapies.
Conclusion
Uri Tabori's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer research. His patents reflect a commitment to improving diagnostic methods and treatment options for patients.